FIRST AMENDMENT TO SETTLEMENT, TERMINATION, ASSET TRANSFER AND TRANSITION AGREEMENTSettlement, Termination, Asset Transfer and Transition Agreement • May 26th, 2017 • Jaguar Animal Health, Inc. • Pharmaceutical preparations
This First Amendment (this “Amendment”) to Settlement, Termination, Asset Transfer and Transition Agreement is made and entered into as of May 10, 2016 (the “Amendment Effective Date”) between Napo Pharmaceuticals, Inc., a Delaware corporation having its principal place of business at 201 Mission Street, Suite 2375, San Francisco, California 94105 (“Napo”) and Salix Pharmaceuticals, Inc., a California corporation having its principal place of business at 400 Somerset Corporate Blvd., Bridgewater, New Jersey 08807 (“Salix”). Napo and Salix may be referred to herein as a “Party” or, collectively, as “Parties.”
